Cellular internalization and cytotoxicity of the antimicrobial proline-rich peptide Bac7(1-35) in monocytes/macrophages, and its activity against phagocytosed salmonella typhimurium

Protein and Peptide Letters

Volumn 21, Issue 4, 2014, Pages 382-390

  Pelillo, Chiara ^a   Benincasa, Monica ^a   Scocchi, Marco ^a   Gennaro, Renato ^a   Tossi, Alessandro ^a   Pacor, Sabrina ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Antibiotic; Antimicrobial peptide; Intracellular infection; Phagocytosis; Proline rich; S. typhimurium

Indexed keywords

POLYPEPTIDE ANTIBIOTIC AGENT; PROLINE RICH ANTIBACTERIAL PEPTIDE BAC7[1-35]; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; APOPTOSIS; ARTICLE; CELL DEATH; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; DRUG CYTOTOXICITY; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; INCUBATION TIME; INNATE IMMUNITY; INTERNALIZATION; INTESTINE LYMPHATIC TISSUE; MACROPHAGE; MINIMUM INHIBITORY CONCENTRATION; MONOCYTE; PHAGOCYTOSIS; SALMONELLA TYPHIMURIUM; SALMONELLOSIS;

ANIMALS; ANTI-INFECTIVE AGENTS; CATTLE; CELL LINE; CELLS, CULTURED; HUMANS; MACROPHAGES; MICE; PEPTIDES, CYCLIC; PHAGOCYTOSIS; SALMONELLA INFECTIONS; SALMONELLA TYPHIMURIUM;

EID: 84896378834     PISSN: 09298665     EISSN: None     Source Type: Journal    
DOI: 10.2174/09298665113206660109     Document Type: Article

References (41)

1. Zasloff, M. Antimicrobial peptides of multicellular organisms. Nature, 2002, 415, 389-395.
2. Yeung, A.T.; Gellatly, S.L.; Hancock, R.E. Multifunctional cationic host defence peptides and their clinical applications. Cell Mol Life Sci., 2011, 68, 2161-2176.
3. Zhang, L.; Falla, T.J. Potential therapeutic application of host defense peptides. Methods Mol Biol., 2010, 618, 303-327.
4. Robinson, M.W.; Hutchinson, A.T.; Donnelly, S. Antimicrobial peptides: utility players in innate immunity. Front Immunol., 2012, 3, 325.
5. Keitel, U.; Schilling, E.; Knappe, D.; Al-Mekhlafi, M.; Petersen, F.; Hoffmann, R.; Hauschildt, S. Effect of antimicrobial peptides from Apis mellifera hemolymph and its optimized version Api88 on biological activities of human monocytes and mast cells. Innate Immun., 2013, 19(4), 355-67.
6. Risso, A.; Zanetti, M.; Gennaro, R. Cytotoxicity and apoptosis mediated by two peptides of innate immunity. Cell Immunol., 1998, 189, 107-115.
7. Scocchi, M.; Tossi, A.; Gennaro, R. Proline-rich antimicrobial peptides: converging to a non-lytic mechanism of action. Cell Mol. Life Sci., 2011, 68, 2317-2330.
8. Benincasa, M.; Scocchi, M.; Podda, E.; Skerlavaj, B.; Dolzani, L.; Gennaro, R. Antimicrobial activity of Bac7 fragments against drugresistant clinical isolates. Peptides, 2004, 25, 2055-2061.
9. Li, W.F.; Ma, G.X.; Zhou, X.X. Apidaecin-type peptides: biodiversity, structure-function relationships and mode of action. Peptides, 2006, 27, 2350-2359.
10. Otvos, L., Jr. The short proline-rich antibacterial peptide family. Cell Mol. Life Sci., 2002, 59, 1138-1150.
11. Gennaro, R.; Zanetti, M.; Benincasa, M.; Podda, E.; Miani, M. Prorich antimicrobial peptides from animals: structure, biological functions and mechanism of action. Curr. Pharm Des., 2002, 8, 763-778.
12. Szabo, D.; Ostorhazi, E.; Binas, A.; Rozgonyi, F.; Kocsis, B.; Cassone, M.; Wade, J.D.; Nolte, O.; Otvos, L., Jr. The designer prolinerich antibacterial peptide A3-APO is effective against systemic Escherichia coli infections in different mouse models. Int. J. Antimicrob. Agents, 2010, 35, 357-361.
13. Ostorhazi, E.; Rozgonyi, F.; Sztodola, A.; Harmos, F.; Kovalszky, I.; Szabo, D.; Knappe, D.; Hoffmann, R.; Cassone, M.; Wade, J.D.; Bonomo, R.A.; Otvos, L. Jr. Preclinical advantages of intramuscularly administered peptide A3-APO over existing therapies in Acinetobacter baumannii wound infections. J. Antimicrob. Chemother., 2010, 65, 2416-2422.
14. Benincasa, M.; Pelillo, C.; Zorzet, S.; Garrovo, C.; Biffi, S.; Gennaro, R.; Scocchi, M. The proline-rich peptide Bac7(1-35) reduces mortality from Salmonella typhimurium in a mouse model of infection. BMC Microbiol., 2010, 10, 178.
15. Gennaro, R.; Skerlavaj, B.; Romeo, D. Purification, composition, and activity of two bactenecins, antibacterial peptides of bovine neutrophils. Infect. Immun., 1989, 57, 3142-3146.
16. Tomasinsig, L.; Skerlavaj, B.; Papo, N.; Giabbai, B.; Shai, Y.; Zanetti, M. Mechanistic and functional studies of the interaction of a proline-rich antimicrobial peptide with mammalian cells. J. Biol. Chem., 2006, 281, 383-391.
17. Jung, C.; Hugot, J.P.; Barreau, F. Peyer's Patches: The Immune Sensors of the Intestine. Int. J. Inflam., 2010, 2010, 823710.
18. Podda, E.; Benincasa, M.; Pacor, S.; Micali, F.; Mattiuzzo, M.; Gennaro, R.; Scocchi, M. Dual mode of action of Bac7, a prolinerich antibacterial peptide. Biochim. Biophys. Acta, 2006, 1760, 1732-1740.
19. Mattiuzzo, M.; Bandiera, A.; Gennaro, R.; Benincasa, M.; Pacor, S.; Antcheva, N.; Scocchi, M. Role of the Escherichia coli SbmA in the antimicrobial activity of proline-rich peptides. Mol. Microbiol., 2007, 66, 151-163.
20. McClelland, M.; Sanderson, K.E.; Spieth, J.; Clifton, S.W.; Latreille, P.; Courtney, L.; Porwollik, S.; Ali, J.; Dante, M.; Du, F.; Hou, S.; Layman, D.; Leonard, S.; Nguyen, C.; Scott, K.; Holmes, A.; Grewal, N.; Mulvaney, E.; Ryan, E.; Sun, H.; Florea, L.; Miller, W.; Stoneking, T.; Nhan, M.; Waterston, R.; Wilson, R.K. Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature, 2001, 413, 852-856.
21. Bennett, S.; Breit, S.N. Variables in the isolation and culture of human monocytes that are of particular relevance to studies of HIV. J. Leukoc. Biol., 1994, 56, 236-240.
22. Benincasa, M.; Pacor, S.; Wu, W.; Prato, M.; Bianco, A.; Gennaro, R. Antifungal activity of amphotericin B conjugated to carbon nanotubes. ACS Nano, 2011, 5, 199-208.
23. Elsinghorst, E.A. Measurement of invasion by gentamicin resistance. Methods Enzymol., 1994, 236, 405-420.
24. Gonzalez Maglio, D.H.; Cela, E.M.; Ferrari, A.; Leoni, J. Mitochondrial function evaluation in epidermal cells ex vivo after ultraviolet irradiation. Exp. Dermatol., 2011, 20, 947-950.
25. Catrina, S.B.; Refai, E.; Andersson, M. The cytotoxic effects of the anti-bacterial peptides on leukocytes. J. Pept. Sci., 2009, 15, 842-848.
26. Risso, A.; Braidot, E.; Sordano, M.C.; Vianello, A.; Macri, F.; Skerlavaj, B.; Zanetti, M.; Gennaro, R.; Bernardi, P. BMAP-28, an antibiotic peptide of innate immunity, induces cell death through opening of the mitochondrial permeability transition pore. Mol. Cell Biol., 2002, 22, 1926-1935.
27. Tavano, R.; Segat, D.; Gobbo, M.; Papini, E. The honeybee antimicrobial peptide apidaecin differentially immunomodulates human macrophages, monocytes and dendritic cells. J. Innate Immun., 2011, 3, 614-622.
28. Slaninova, J.; Mlsova, V.; Kroupova, H.; Alan, L.; Tumova, T.; Monincova, L.; Borovickova, L.; Fucik, V.; Cerovsky, V. Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells. Peptides, 2011, 33, 18-26.
29. Anderson, K.M.; Ondrey, F.G.; Harris, J.E. 5,8,11,14- eicosatetraynoic acid-induced differentiation of U937 cells. Ann. Clin. Lab Sci., 1989, 19, 92-100.
30. Hu, X.; Janssen, W.E.; Moscinski, L.C.; Bryington, M.; Dangsupa, A.; Rezai-Zadeh, N.; Babbin, B.A.; Zuckerman, K.S. An Ikappa-Balpha inhibitor causes leukemia cell death through a p38 MAP kinase-dependent, NF-kappaB-independent mechanism. Cancer Res., 2001, 61, 6290-6296.
31. Silva, M.T. Neutrophils and macrophages work in concert as inducers and effectors of adaptive immunity against extracellular and intracellular microbial pathogens. J. Leukoc. Biol., 2010, 87, 805-813.
32. Mordue, D.G.; Sibley, L.D. A novel population of Gr-1+-activated macrophages induced during acute toxoplasmosis. J. Leukoc. Biol., 2003, 74, 1015-1025.
33. Tam, M.A.; Rydstrom, A.; Sundquist, M.; Wick, M.J. Early cellular responses to Salmonella infection: dendritic cells, monocytes, and more. Immunol. Rev., 2008, 225, 140-162.
34. Bruno, V.M.; Hannemann, S.; Lara-Tejero, M.; Flavell, R.A.; Kleinstein, S.H.; Galan, J.E. Salmonella Typhimurium type III secretion effectors stimulate innate immune responses in cultured epithelial cells. PLoS Pathog., 2009, 5, e1000538.
35. Hapfelmeier, S.; Hardt, W.D. A mouse model for S. typhimuriuminduced enterocolitis. Trends Microbiol., 2005, 13, 497-503.
36. Crump, J.A.; Mintz, E.D. Global trends in typhoid and paratyphoid Fever. Clin. Infect. Dis., 2010, 50, 241-246.
37. de Jong, H.K.; Parry, C.M.; van der Poll, T.; Wiersinga, W.J. Hostpathogen interaction in invasive Salmonellosis. PLoS Pathog., 2012, 8, e1002933.
38. Helaine, S.; Thompson, J.A.; Watson, K.G.; Liu, M.; Boyle, C.; Holden, D.W. Dynamics of intracellular bacterial replication at the single cell level. Proc. Natl. Acad. Sci. USA, 2010, 107, 3746-3751.
39. Mosser, D.M.; Edwards, J.P. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol., 2008, 8, 958-969.
40. Kim, B.; Richards, S.M.; Gunn, J.S.; Slauch, J.M. Protecting against antimicrobial effectors in the phagosome allows SodCII to contribute to virulence in Salmonella enterica serovar Typhimurium. J. Bacteriol., 2010, 192, 2140-2149.
41. Slauch, J.M. How does the oxidative burst of macrophages kill bacteria? Still an open question. Mol. Microbiol., 2011, 80, 580-583.